LaserSight LaserScan LSX For LASIK Myopia Correction To Ship By Year-End

LaserSight LaserScan LSX systems equipped for laser in-situ keratomileusis (LASIK) treatment of myopia with or without astigmatism will ship by year-end following FDA approval of the expanded indication.

More from Archive

More from Medtech Insight